Next 10 |
2024-06-06 09:01:56 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst Non-GAAP EPS of $0.05 beats by $0.02, revenue of $74.72M misses by $0.09M t Read the full article on Seeking Alpha For further de...
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...
2024-05-21 18:30:04 ET Raymond James analyst issues UNDERPERFORM recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Underperform. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-05-21 18:30:04 ET Wells Fargo analyst issues BUY recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Buy. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite® PR Newswire SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of da...
2024-05-09 22:50:25 ET Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Conference Call May 09, 2024, 17:00 ET Company Participants Jack Knight - VP, Investor Relations Daniel Burton - CEO & Director Jason Alger - CFO Conference Call Participants Jar...
2024-05-09 17:07:28 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade) Health Ca...
SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. “For the...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-08 17:35:54 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade) R1 RCM, H...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Inc Company Name:
HCAT Stock Symbol:
NYSE Market:
Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because in...
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...
2024-05-21 18:30:04 ET Raymond James analyst issues UNDERPERFORM recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Underperform. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BU...